Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Elizabeth Pomfret

Concepts (508)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
125
2024
800
17.450
 Why?
Living Donors
74
2023
287
13.100
 Why?
Tissue and Organ Procurement
35
2024
288
6.610
 Why?
Hepatectomy
24
2023
210
3.320
 Why?
Donor Selection
16
2024
75
3.280
 Why?
Tissue Donors
16
2024
388
2.670
 Why?
Kidney Transplantation
15
2024
603
2.570
 Why?
End Stage Liver Disease
12
2023
78
2.470
 Why?
Organ Transplantation
14
2024
218
2.150
 Why?
Carcinoma, Hepatocellular
9
2023
271
2.100
 Why?
Liver
42
2023
1827
2.070
 Why?
Patient Selection
14
2023
661
2.040
 Why?
Perfusion
7
2024
188
1.920
 Why?
Liver Neoplasms
10
2023
637
1.770
 Why?
Postoperative Complications
27
2024
2462
1.620
 Why?
Liver Cirrhosis
9
2020
279
1.390
 Why?
Tissue and Organ Harvesting
10
2024
72
1.360
 Why?
Waiting Lists
15
2023
237
1.230
 Why?
Graft Survival
18
2023
503
1.120
 Why?
Humans
175
2025
128495
1.090
 Why?
Laparoscopy
3
2023
450
1.010
 Why?
Informed Consent
3
2024
168
0.990
 Why?
Fatty Liver
6
2023
231
0.980
 Why?
Hepatitis C, Chronic
5
2022
153
0.960
 Why?
Liver Diseases
5
2023
287
0.890
 Why?
Immunotoxins
4
2025
54
0.820
 Why?
Consensus
9
2024
610
0.800
 Why?
Consensus Development Conferences as Topic
2
2020
27
0.790
 Why?
United States
37
2024
13840
0.790
 Why?
Robotic Surgical Procedures
2
2024
109
0.780
 Why?
Graft Rejection
13
2020
557
0.770
 Why?
Organ Preservation
5
2024
92
0.760
 Why?
Liver Failure
7
2016
91
0.710
 Why?
Surgeons
2
2024
259
0.700
 Why?
Frailty
1
2023
153
0.660
 Why?
Pain, Postoperative
3
2016
222
0.660
 Why?
Adult
71
2024
35299
0.640
 Why?
Portal Vein
4
2017
107
0.640
 Why?
Diphtheria Toxin
4
2025
64
0.620
 Why?
Resource Allocation
4
2013
39
0.620
 Why?
Immunosuppressive Agents
6
2018
684
0.590
 Why?
Middle Aged
65
2024
30921
0.590
 Why?
Female
82
2025
68266
0.570
 Why?
Male
83
2024
63043
0.570
 Why?
Treatment Outcome
33
2024
10162
0.560
 Why?
Hepatic Veins
5
2016
31
0.540
 Why?
Thrombelastography
6
2023
150
0.530
 Why?
Antiviral Agents
4
2022
711
0.500
 Why?
Healthcare Disparities
5
2023
579
0.500
 Why?
Blood Coagulation Disorders
4
2022
167
0.500
 Why?
Venous Thrombosis
1
2017
176
0.490
 Why?
Non-alcoholic Fatty Liver Disease
1
2019
258
0.490
 Why?
Biliary Tract Surgical Procedures
2
2017
25
0.490
 Why?
Transplantation, Homologous
8
2020
389
0.480
 Why?
Biopsy
9
2020
1079
0.470
 Why?
Societies, Medical
4
2024
744
0.470
 Why?
Sirolimus
1
2016
190
0.460
 Why?
Retrospective Studies
30
2024
14471
0.450
 Why?
Kidney
6
2023
1310
0.440
 Why?
Interleukin-2
4
2024
434
0.430
 Why?
Tissue Plasminogen Activator
4
2023
222
0.430
 Why?
Biliary Tract Diseases
2
2010
36
0.420
 Why?
Neoplasm Recurrence, Local
4
2023
958
0.410
 Why?
Hepacivirus
7
2022
235
0.410
 Why?
Periodicals as Topic
1
2015
203
0.400
 Why?
Tomography, X-Ray Computed
9
2017
2517
0.400
 Why?
Kidney Failure, Chronic
3
2023
541
0.380
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2012
99
0.380
 Why?
Hepatitis C
5
2022
237
0.380
 Why?
Lymphoma, T-Cell, Cutaneous
2
2023
43
0.370
 Why?
Survival Rate
13
2023
1871
0.370
 Why?
Transplant Recipients
6
2023
153
0.350
 Why?
Liver Regeneration
4
2003
40
0.350
 Why?
Allografts
3
2023
136
0.340
 Why?
Resuscitation
2
2024
234
0.340
 Why?
Patient Safety
1
2012
286
0.320
 Why?
Blood Coagulation
5
2023
236
0.310
 Why?
Biliary Tract
1
2008
15
0.310
 Why?
Directed Tissue Donation
1
2008
4
0.310
 Why?
Bioethical Issues
1
2008
8
0.310
 Why?
Terminology as Topic
3
2024
199
0.310
 Why?
Vascular Surgical Procedures
1
2011
294
0.300
 Why?
Adolescent
23
2024
20304
0.300
 Why?
Quality of Life
7
2020
2688
0.300
 Why?
Interpersonal Relations
1
2011
390
0.290
 Why?
Risk Factors
16
2024
9737
0.290
 Why?
Software
2
2012
608
0.290
 Why?
Severity of Illness Index
8
2023
2719
0.290
 Why?
Transplants
2
2022
35
0.280
 Why?
Tacrolimus
3
2020
140
0.280
 Why?
Time Factors
15
2024
6505
0.280
 Why?
Registries
5
2024
1883
0.270
 Why?
Fibrinolysis
3
2023
137
0.270
 Why?
Amyloid Neuropathies, Familial
1
2006
14
0.270
 Why?
Young Adult
12
2024
12349
0.270
 Why?
Aged
29
2024
21974
0.260
 Why?
Transplantation Immunology
1
2006
33
0.250
 Why?
Antineoplastic Agents
3
2024
2042
0.250
 Why?
Insurance, Life
1
2005
2
0.250
 Why?
International Cooperation
2
2016
173
0.240
 Why?
Follow-Up Studies
11
2024
4874
0.240
 Why?
CD47 Antigen
1
2025
28
0.240
 Why?
Flank Pain
1
2024
9
0.230
 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2025
26
0.230
 Why?
Renal Nutcracker Syndrome
1
2024
6
0.230
 Why?
Critical Care
4
2024
551
0.230
 Why?
Practice Guidelines as Topic
5
2019
1490
0.230
 Why?
Decision Making
1
2011
847
0.230
 Why?
Health Care Rationing
3
2013
57
0.230
 Why?
Intestines
2
2007
344
0.230
 Why?
Skin Neoplasms
2
2023
820
0.220
 Why?
Solitary Kidney
1
2023
5
0.220
 Why?
Physician-Patient Relations
1
2008
530
0.220
 Why?
Transplantation, Autologous
1
2024
211
0.220
 Why?
Prognosis
9
2024
3780
0.210
 Why?
Risk Assessment
9
2022
3232
0.210
 Why?
Sezary Syndrome
1
2023
44
0.210
 Why?
Body Mass Index
2
2024
2263
0.210
 Why?
Mycosis Fungoides
1
2023
63
0.210
 Why?
Length of Stay
3
2023
1119
0.210
 Why?
Health Knowledge, Attitudes, Practice
1
2011
1276
0.210
 Why?
Body Temperature
1
2023
212
0.200
 Why?
Primary Graft Dysfunction
1
2023
29
0.200
 Why?
Lung Transplantation
2
2024
278
0.200
 Why?
Operative Time
1
2023
121
0.200
 Why?
Thrombosis
3
2022
343
0.190
 Why?
Death
3
2023
121
0.190
 Why?
Adenocarcinoma, Mucinous
1
2023
75
0.190
 Why?
Bile Ducts
2
2022
67
0.190
 Why?
Case-Control Studies
5
2023
3339
0.190
 Why?
Sodium
1
2022
202
0.190
 Why?
Massachusetts
2
2012
158
0.190
 Why?
Antibiotic Prophylaxis
2
2020
101
0.190
 Why?
Evidence-Based Medicine
3
2016
712
0.180
 Why?
Sex Factors
3
2024
1951
0.180
 Why?
Recurrence
10
2011
1004
0.180
 Why?
Prospective Studies
11
2020
7069
0.180
 Why?
Predictive Value of Tests
5
2020
1938
0.180
 Why?
Prothrombin Time
1
2000
33
0.180
 Why?
Physicians
2
2010
863
0.180
 Why?
Cholangitis, Sclerosing
3
2009
71
0.180
 Why?
Bupivacaine
1
2000
30
0.170
 Why?
Analgesia, Epidural
1
2000
23
0.170
 Why?
Reperfusion
1
2020
36
0.170
 Why?
Temperature
1
2023
632
0.170
 Why?
Feasibility Studies
1
2024
863
0.170
 Why?
Epidermal Growth Factor
1
2021
170
0.170
 Why?
Diagnostic Imaging
2
2013
332
0.170
 Why?
Educational Status
3
2022
470
0.170
 Why?
Mitochondrial Encephalomyopathies
1
2020
8
0.170
 Why?
Anesthetics, Local
1
2000
74
0.170
 Why?
Thymidine Phosphorylase
1
2020
14
0.170
 Why?
Costs and Cost Analysis
3
2024
200
0.170
 Why?
Hemostatic Techniques
1
2020
45
0.170
 Why?
Cholestasis
1
2023
229
0.170
 Why?
Blood Component Transfusion
1
2020
82
0.170
 Why?
Carcinoma, Pancreatic Ductal
1
2023
268
0.160
 Why?
Choline
4
1989
120
0.160
 Why?
Policy
1
2021
144
0.160
 Why?
Reproducibility of Results
4
2012
3021
0.160
 Why?
Surgical Wound Infection
1
2022
282
0.160
 Why?
Medicare
1
2024
719
0.160
 Why?
Nephrectomy
1
2020
158
0.160
 Why?
Viremia
1
2020
131
0.160
 Why?
Biliary Atresia
1
2020
161
0.150
 Why?
Risk
3
2016
853
0.150
 Why?
Catheterization
2
2023
173
0.150
 Why?
Gastric Bypass
1
2020
107
0.150
 Why?
Amyloid Neuropathies
1
1998
1
0.150
 Why?
Age Distribution
2
2011
373
0.150
 Why?
Mice, SCID
3
2025
350
0.150
 Why?
Bile Duct Diseases
1
2017
14
0.140
 Why?
Telomerase
1
2020
231
0.140
 Why?
Phlebography
1
2017
38
0.140
 Why?
Prevalence
3
2023
2553
0.140
 Why?
Head and Neck Neoplasms
1
2022
533
0.140
 Why?
Premature Birth
1
2021
310
0.140
 Why?
Obesity, Morbid
2
2020
240
0.140
 Why?
Reoperation
6
2017
544
0.140
 Why?
Drug Overdose
1
2021
321
0.140
 Why?
Incidental Findings
1
2017
79
0.140
 Why?
Asymptomatic Diseases
1
2017
84
0.140
 Why?
Ultrasonography, Doppler
1
2017
118
0.140
 Why?
Bariatric Surgery
1
2020
192
0.130
 Why?
Surveys and Questionnaires
4
2016
5371
0.130
 Why?
Child
8
2022
20805
0.130
 Why?
Incidence
5
2020
2638
0.130
 Why?
Social Determinants of Health
1
2020
221
0.130
 Why?
Cause of Death
2
2021
392
0.130
 Why?
Antibodies, Monoclonal
3
2024
1357
0.130
 Why?
Perioperative Care
1
2017
150
0.130
 Why?
Disease Progression
4
2019
2604
0.130
 Why?
Communicable Diseases
1
2017
145
0.120
 Why?
Iron
1
2017
282
0.120
 Why?
Postoperative Care
1
2017
237
0.120
 Why?
Cohort Studies
8
2021
5402
0.120
 Why?
Postoperative Period
4
2020
323
0.120
 Why?
Morbidity
2
2013
301
0.120
 Why?
Mycophenolic Acid
2
2014
89
0.120
 Why?
Randomized Controlled Trials as Topic
2
2022
1358
0.120
 Why?
Xenograft Model Antitumor Assays
3
2025
812
0.120
 Why?
Pancreatic Neoplasms
1
2023
878
0.120
 Why?
Monitoring, Physiologic
2
1994
264
0.120
 Why?
Chemoembolization, Therapeutic
1
2015
48
0.120
 Why?
Parents
2
2020
1307
0.120
 Why?
Cadaver
3
2015
306
0.120
 Why?
Organ Size
2
2012
441
0.120
 Why?
Antilymphocyte Serum
1
2014
63
0.110
 Why?
Withholding Treatment
1
2014
70
0.110
 Why?
Coronary Artery Disease
1
2020
676
0.110
 Why?
Opioid-Related Disorders
1
2021
482
0.110
 Why?
Comorbidity
1
2019
1541
0.110
 Why?
Mitochondria
1
2020
855
0.110
 Why?
Steroids
1
2014
147
0.110
 Why?
Choline Deficiency
3
1991
11
0.110
 Why?
Splenorenal Shunt, Surgical
2
2006
3
0.110
 Why?
Immunophenotyping
1
2014
309
0.100
 Why?
Thoracic Injuries
1
1993
55
0.100
 Why?
Physician Executives
1
2013
33
0.100
 Why?
Data Collection
2
2013
649
0.100
 Why?
Anticoagulants
1
2017
634
0.100
 Why?
Anesthesiology
1
2013
45
0.100
 Why?
Cooperative Behavior
1
2015
424
0.100
 Why?
Catheterization, Central Venous
1
1994
103
0.100
 Why?
Receptors, CCR4
2
2024
21
0.100
 Why?
Personnel Selection
1
2013
72
0.100
 Why?
Therapeutic Equipoise
1
2011
2
0.100
 Why?
Liver Function Tests
2
2020
107
0.090
 Why?
Mice
6
2025
16620
0.090
 Why?
Mental Health
1
2018
683
0.090
 Why?
Catheter Ablation
1
2015
334
0.090
 Why?
Cell Line, Tumor
3
2025
3178
0.090
 Why?
Mice, Inbred NOD
2
2025
586
0.090
 Why?
Religion
1
2011
68
0.090
 Why?
Anastomosis, Surgical
1
2011
149
0.090
 Why?
Kaplan-Meier Estimate
2
2011
856
0.090
 Why?
Family Relations
1
2011
88
0.090
 Why?
Animals
14
2025
34647
0.090
 Why?
Observer Variation
1
2011
313
0.090
 Why?
Health Status Indicators
1
2011
167
0.090
 Why?
Anastomosis, Roux-en-Y
2
2022
27
0.090
 Why?
Hepatitis, Autoimmune
4
2006
20
0.090
 Why?
Wounds, Nonpenetrating
1
1993
272
0.080
 Why?
Health Planning Guidelines
1
2010
24
0.080
 Why?
Specialties, Surgical
1
2011
73
0.080
 Why?
Hypertension, Portal
1
2010
60
0.080
 Why?
Critical Illness
1
2015
755
0.080
 Why?
Constriction, Pathologic
2
2023
228
0.080
 Why?
Obesity
4
2024
2864
0.080
 Why?
Mutation
1
2020
3696
0.080
 Why?
Models, Biological
2
2006
1698
0.080
 Why?
S-Adenosylmethionine
1
1989
52
0.080
 Why?
North America
2
2023
290
0.080
 Why?
Linear Models
1
2011
816
0.080
 Why?
Proportional Hazards Models
3
2020
1200
0.080
 Why?
Bile Ducts, Intrahepatic
1
2009
65
0.080
 Why?
Life Expectancy
1
2009
61
0.080
 Why?
Rats, Inbred Strains
7
1991
362
0.080
 Why?
Methionine
1
1989
157
0.080
 Why?
Brain Death
2
2024
46
0.070
 Why?
Adrenal Cortex Hormones
1
2011
518
0.070
 Why?
Ventilator Weaning
1
2008
37
0.070
 Why?
General Surgery
1
2010
152
0.070
 Why?
Rats
8
2024
5246
0.070
 Why?
Guidelines as Topic
1
2010
260
0.070
 Why?
Lithium
1
1988
37
0.070
 Why?
Pulmonary Artery
1
1994
1031
0.070
 Why?
Documentation
2
2024
183
0.070
 Why?
Recombinant Fusion Proteins
2
2021
636
0.070
 Why?
Immunoglobulin G
1
2011
844
0.070
 Why?
Hypotension
1
2008
115
0.070
 Why?
Abdomen
2
2024
118
0.070
 Why?
Prealbumin
1
2006
28
0.070
 Why?
Heart Failure
1
2020
2145
0.070
 Why?
Antibodies, Monoclonal, Humanized
1
2011
758
0.070
 Why?
Parenteral Nutrition, Total
2
2003
26
0.060
 Why?
Survival Analysis
4
2015
1265
0.060
 Why?
Demography
1
2007
278
0.060
 Why?
Neoplasm Staging
1
2009
1292
0.060
 Why?
Safety
1
2008
328
0.060
 Why?
Esophageal and Gastric Varices
1
2006
37
0.060
 Why?
Transplantation
1
2005
25
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
120
0.060
 Why?
Renal Veins
1
2024
16
0.060
 Why?
Pain
2
2022
751
0.060
 Why?
Algorithms
2
2011
1614
0.060
 Why?
Practice Patterns, Physicians'
1
2013
1262
0.060
 Why?
Xanthomatosis
1
2004
11
0.060
 Why?
Employment
1
2005
167
0.050
 Why?
Swine, Miniature
1
2024
79
0.050
 Why?
Salvage Therapy
1
2024
134
0.050
 Why?
Granuloma
1
2004
83
0.050
 Why?
Bilirubin
1
2023
93
0.050
 Why?
Depression
2
2018
1292
0.050
 Why?
Patient Care
1
2004
108
0.050
 Why?
Liver Cirrhosis, Biliary
1
2003
18
0.050
 Why?
Shock
1
2024
92
0.050
 Why?
Choledochostomy
1
2022
11
0.050
 Why?
T-Lymphocytes
2
2014
1923
0.050
 Why?
Perioperative Period
1
2022
48
0.050
 Why?
Research
1
2006
409
0.050
 Why?
Syndrome
1
2023
336
0.050
 Why?
Infant
3
2021
9001
0.050
 Why?
Platelet Count
1
2022
82
0.050
 Why?
Laboratories
1
2023
109
0.050
 Why?
Mentors
1
2024
178
0.050
 Why?
Liver Cirrhosis, Alcoholic
1
2002
17
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2022
84
0.050
 Why?
Propensity Score
1
2023
265
0.050
 Why?
Platelet Transfusion
1
2022
59
0.050
 Why?
Pain Measurement
1
2024
488
0.050
 Why?
Cell Differentiation
1
2009
1900
0.050
 Why?
RNA, Viral
3
2013
615
0.050
 Why?
Patients
1
2023
167
0.050
 Why?
Hypophosphatemia
1
2001
17
0.050
 Why?
Swine
1
2024
742
0.050
 Why?
Creatinine
1
2023
480
0.050
 Why?
Family
1
2005
649
0.050
 Why?
Leukocytes, Mononuclear
1
2024
539
0.040
 Why?
Erlotinib Hydrochloride
1
2021
69
0.040
 Why?
Intraoperative Period
1
2020
53
0.040
 Why?
Histocompatibility Testing
1
2020
120
0.040
 Why?
Computer Systems
1
2020
44
0.040
 Why?
Pancreas
1
2023
306
0.040
 Why?
Viscosity
1
2020
89
0.040
 Why?
Preoperative Care
1
2022
336
0.040
 Why?
Thymidine
1
2020
59
0.040
 Why?
Inhibitory Concentration 50
1
2020
82
0.040
 Why?
Kidney Function Tests
1
2020
145
0.040
 Why?
Infant, Newborn
2
2021
5740
0.040
 Why?
Interleukin-2 Receptor alpha Subunit
1
2020
76
0.040
 Why?
Esophageal Motility Disorders
1
2020
26
0.040
 Why?
Remission Induction
1
2020
268
0.040
 Why?
HLA-DR Antigens
1
2020
224
0.040
 Why?
Sex Distribution
1
2020
358
0.040
 Why?
ErbB Receptors
1
2022
603
0.040
 Why?
Hemangioma, Cavernous
1
1999
13
0.040
 Why?
Image Processing, Computer-Assisted
2
2001
737
0.040
 Why?
Gastrectomy
1
2020
99
0.040
 Why?
Renal Dialysis
1
2023
423
0.040
 Why?
Blood Platelets
1
2022
377
0.040
 Why?
Hypertension, Pulmonary
1
2010
1749
0.040
 Why?
HLA Antigens
1
2020
234
0.040
 Why?
Age Factors
2
2021
3122
0.040
 Why?
Peripheral Nervous System Diseases
1
2020
121
0.040
 Why?
Tumor Microenvironment
1
2022
624
0.040
 Why?
Pregnancy Outcome
1
2021
390
0.040
 Why?
Pilot Projects
2
2014
1568
0.040
 Why?
Coronary Angiography
1
2020
306
0.040
 Why?
Longitudinal Studies
1
2005
2710
0.040
 Why?
Anatomic Variation
1
2017
3
0.040
 Why?
Hepcidins
1
2017
22
0.040
 Why?
Nervous System
1
1998
66
0.040
 Why?
Pancreas Transplantation
2
2009
74
0.040
 Why?
Mammary Glands, Animal
2
1988
124
0.040
 Why?
Ferritins
1
2017
58
0.040
 Why?
Boston
1
2017
86
0.040
 Why?
Chi-Square Distribution
2
2011
512
0.040
 Why?
Hepatic Artery
3
2003
58
0.040
 Why?
Phosphatidylcholines
2
1988
146
0.030
 Why?
Analgesics, Opioid
1
2024
889
0.030
 Why?
Recombinant Proteins
1
2020
1291
0.030
 Why?
Cardiovascular System
1
1998
137
0.030
 Why?
Communication
1
2022
841
0.030
 Why?
Sepsis
1
2022
569
0.030
 Why?
Flow Cytometry
1
2020
1142
0.030
 Why?
Databases, Factual
1
2021
1267
0.030
 Why?
Immunocompromised Host
1
2017
196
0.030
 Why?
Hepatic Encephalopathy
1
2015
19
0.030
 Why?
Hepatorenal Syndrome
1
2015
14
0.030
 Why?
Acute-On-Chronic Liver Failure
1
2015
7
0.030
 Why?
Cross Infection
1
1998
216
0.030
 Why?
Fatigue
1
2018
316
0.030
 Why?
Contrast Media
2
2013
390
0.030
 Why?
Contraindications
2
2006
89
0.030
 Why?
Peritonitis
1
2015
81
0.030
 Why?
Benchmarking
1
2016
175
0.030
 Why?
Protein Kinase Inhibitors
1
2021
880
0.030
 Why?
Aged, 80 and over
4
2011
7057
0.030
 Why?
Delivery of Health Care
1
2022
889
0.030
 Why?
Cluster Analysis
1
2016
479
0.030
 Why?
Fluid Therapy
1
2015
134
0.030
 Why?
Host-Pathogen Interactions
1
2017
349
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
575
0.030
 Why?
Mesothelioma
2
1985
38
0.030
 Why?
Social Class
1
2016
258
0.030
 Why?
Blood Transfusion
1
2016
295
0.030
 Why?
Genotype
2
2013
1830
0.030
 Why?
Peritoneal Neoplasms
2
1985
87
0.030
 Why?
Equipment Failure
1
1994
107
0.030
 Why?
Constitution and Bylaws
1
2013
1
0.030
 Why?
Chromatography, High Pressure Liquid
3
1991
488
0.030
 Why?
Pandemics
1
2021
1477
0.030
 Why?
Decision Trees
1
1993
90
0.030
 Why?
Hospitals, Low-Volume
1
2013
22
0.030
 Why?
Respiratory Mechanics
1
1993
63
0.030
 Why?
Pediatrics
1
2001
1050
0.030
 Why?
Hospitals, High-Volume
1
2013
39
0.030
 Why?
Rabbits
1
2014
775
0.030
 Why?
Certification
1
2013
94
0.020
 Why?
Viral Envelope Proteins
1
2013
80
0.020
 Why?
Clinical Protocols
1
1993
254
0.020
 Why?
Multivariate Analysis
1
2015
1499
0.020
 Why?
Cost-Benefit Analysis
1
2014
569
0.020
 Why?
Alcoholism
1
2018
765
0.020
 Why?
Health Care Surveys
1
2013
558
0.020
 Why?
Emotions
1
2016
535
0.020
 Why?
Patient Readmission
1
2016
665
0.020
 Why?
Cardiopulmonary Resuscitation
1
1993
224
0.020
 Why?
Anxiety
1
2018
952
0.020
 Why?
Education
1
2011
100
0.020
 Why?
Biomechanical Phenomena
1
1993
763
0.020
 Why?
Pregnancy
2
2021
6373
0.020
 Why?
Polymerase Chain Reaction
2
2004
1027
0.020
 Why?
Research Design
1
2016
1036
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1951
0.020
 Why?
Biological Transport
2
1988
396
0.020
 Why?
Respiratory Insufficiency
1
1993
311
0.020
 Why?
Diagnosis, Differential
2
2004
1412
0.020
 Why?
Methotrexate
1
1991
249
0.020
 Why?
Folic Acid
1
1991
184
0.020
 Why?
Diabetes Mellitus
1
1998
996
0.020
 Why?
Ursodeoxycholic Acid
1
2009
19
0.020
 Why?
Cholagogues and Choleretics
1
2009
8
0.020
 Why?
Workload
1
2011
151
0.020
 Why?
Ethics, Medical
1
2010
78
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
1989
127
0.020
 Why?
Leadership
1
2013
352
0.020
 Why?
Education, Medical, Graduate
1
2013
435
0.020
 Why?
Guideline Adherence
1
2013
524
0.020
 Why?
Drug Therapy, Combination
1
2011
1016
0.020
 Why?
Phosphatidylethanolamines
1
1988
74
0.020
 Why?
Life Style
1
2011
459
0.020
 Why?
Health Policy
1
2011
351
0.020
 Why?
Prednisone
1
2009
230
0.020
 Why?
Double-Blind Method
1
2013
1856
0.020
 Why?
Methyltransferases
1
1988
70
0.020
 Why?
Magnetic Resonance Imaging
1
2020
3387
0.020
 Why?
Blood Glucose
1
1998
2092
0.020
 Why?
Gastroenterology
1
2010
174
0.020
 Why?
Breast
1
1988
152
0.020
 Why?
Academic Medical Centers
1
2011
480
0.020
 Why?
Acute Kidney Injury
1
2015
779
0.020
 Why?
Models, Theoretical
1
2011
542
0.020
 Why?
Betaine
1
1988
72
0.020
 Why?
Selenium Compounds
1
1987
21
0.020
 Why?
Selenium
1
1987
36
0.020
 Why?
Needs Assessment
1
2010
356
0.020
 Why?
Child, Preschool
1
2021
10487
0.020
 Why?
Organometallic Compounds
1
1987
106
0.020
 Why?
Fellowships and Scholarships
1
2010
272
0.020
 Why?
Biomarkers
1
2017
3893
0.020
 Why?
Intubation, Intratracheal
1
2008
238
0.020
 Why?
Clinical Competence
1
2013
1009
0.020
 Why?
Anti-Inflammatory Agents
1
2009
470
0.020
 Why?
Survivors
1
2009
462
0.020
 Why?
Cross-Sectional Studies
1
2016
5045
0.010
 Why?
Podophyllotoxin
1
1984
7
0.010
 Why?
Etoposide
1
1984
148
0.010
 Why?
Carcinoma, Small Cell
1
1984
168
0.010
 Why?
Tissue Adhesions
1
2004
31
0.010
 Why?
Lacerations
1
2004
29
0.010
 Why?
Liver Diseases, Alcoholic
1
2004
89
0.010
 Why?
Curriculum
1
2010
910
0.010
 Why?
Internship and Residency
1
2013
1045
0.010
 Why?
Intraoperative Complications
1
2004
129
0.010
 Why?
Intestinal Mucosa
1
1988
581
0.010
 Why?
Angiography
1
2003
192
0.010
 Why?
Inflammation
1
1993
2666
0.010
 Why?
Hepatitis C Antibodies
1
2002
9
0.010
 Why?
Erythrocytes
1
1988
673
0.010
 Why?
Azathioprine
1
2001
49
0.010
 Why?
Blood Pressure
1
2008
1712
0.010
 Why?
Spleen
1
2003
509
0.010
 Why?
Secondary Prevention
1
2001
219
0.010
 Why?
Ischemia
1
2003
394
0.010
 Why?
Inflammatory Bowel Diseases
1
2003
320
0.010
 Why?
Autoimmune Diseases
1
2003
424
0.010
 Why?
APACHE
1
1998
65
0.010
 Why?
Imaging, Three-Dimensional
1
2001
529
0.010
 Why?
Surgical Procedures, Operative
1
1999
243
0.010
 Why?
Diabetes Complications
1
1998
223
0.010
 Why?
Sensitivity and Specificity
1
2000
1817
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1983
1562
0.010
 Why?
Lung Neoplasms
1
1984
2329
0.010
 Why?
Combined Modality Therapy
2
1985
1201
0.010
 Why?
Pteroylpolyglutamic Acids
1
1991
1
0.010
 Why?
Tetrahydrofolates
1
1991
18
0.010
 Why?
Phosphatidylethanolamine N-Methyltransferase
1
1988
8
0.000
 Why?
Hemicholinium 3
1
1988
1
0.000
 Why?
Dinitrophenols
1
1988
8
0.000
 Why?
2,4-Dinitrophenol
1
1988
8
0.000
 Why?
Ouabain
1
1988
18
0.000
 Why?
Osmolar Concentration
1
1988
165
0.000
 Why?
Methylation
1
1988
227
0.000
 Why?
Selenium Radioisotopes
1
1987
2
0.000
 Why?
Selenious Acid
1
1987
3
0.000
 Why?
Selenomethionine
1
1987
3
0.000
 Why?
Milk
1
1988
119
0.000
 Why?
Lactation
1
1988
170
0.000
 Why?
Epithelium
1
1988
306
0.000
 Why?
In Vitro Techniques
1
1988
1047
0.000
 Why?
Drug Evaluation
1
1984
80
0.000
 Why?
Kinetics
1
1988
1623
0.000
 Why?
Asbestos
1
1983
28
0.000
 Why?
Laparotomy
1
1983
106
0.000
 Why?
Epithelial Cells
1
1988
1043
0.000
 Why?
Palliative Care
1
1985
717
0.000
 Why?
Pomfret's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (508) concept(s)
_
Co-Authors Expand Description
See all (61) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)